Newsletter subscription & archive

Workshop on Scientific Advice

Open Space Lab on Informal Scientific Advice to Entrepreneurial “Newcomers” and Companies (SMEs) in the Development of Medicinal Products - What you need to know to understand regulatory requirements


21-11-2019 09:00 - 15:00


Maersk Tower, University of Copenhagen, Room 7.15.92, 15th floor
Blegdamsvej 3B
2200 - Copenhagen


Biopeople, The Danish Medicines Agency

The Danish Medicines Agency and Denmark’s Life Science Cluster, Biopeople, are pleased to announce this event. It is open to entrepreneurial researchers and employees in companies that are in need to know more about the regulatory pathways and opportunities for medicines development.

Participation is free of charge and includes any material, water, coffee, tea and a lunch sandwich.

Registration is mandatory - here.

The no-show fee is 5.000 DKK. The event is limited to ca. 50 participants; the organisers decide potential overbooking. Registrated participants will receive a final confirmation no later than 1 November 2019.



9:00 Arrival and registration, welcome by Per Spindler (Director), Biopeople, Denmark’s Life Science Cluster

9:30 Anja Schiel (Senior Advisor and Statistician), Norwegian Medicines Agency. Chair the Scientific Advice Working Party of the Committee for Medicinal Products for Human Use

  • An introduction to scientific advice and protocol assistance at the European Medicines Agency
  • European Medicines Agency’s assistance to small pharmaceutical companies
  • Orphan medicinal products

10:30 Break

10:45 Louise F.S. Bang-Lauritsen (Non-Clinical Assessor), Danish Medicines Agency

  • Non-clinical safety

11:05 Pernille Sterling (Senior Preclinical Assessor) & Louise Jørgensen (Clinical Assessor), Danish Medicines Agency

  • Clinical trials and First-In-Human

11:30 Lunch

12:30 Sinan B. Sarac (Chief Medical Officer), Danish Medicines Agency, Member of the Committee for Medicinal Products for Human Use, the European Medicines Agency

  • National Scientific Advice at the Danish Medicines Agency
  • Clinical safety and efficacy, methodology and statistics
  • Cases

13:45 Networking and QA session on the European Medicines Agency, National Scientific Advice, Non-clinical safety and First-In-Human

15:00 Farewell


For further information contact: Per Spindler, Director, Biopeople, or Randi Krogsgaard, Cluster Manager, Biopeople



What are you looking for?